2-(3,5-Dibromo-4-methoxyphenyl)-5,6,7,8-tetrahydropyridylthieno[2,3-d]pyrimidin-4(3H)-one trifluoroacetic acid

ID: ALA4758661

PubChem CID: 162658353

Max Phase: Preclinical

Molecular Formula: C18H14Br2F3N3O4S

Molecular Weight: 471.17

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1c(Br)cc(-c2nc3sc4c(c3c(=O)[nH]2)CCNC4)cc1Br.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C16H13Br2N3O2S.C2HF3O2/c1-23-13-9(17)4-7(5-10(13)18)14-20-15(22)12-8-2-3-19-6-11(8)24-16(12)21-14;3-2(4,5)1(6)7/h4-5,19H,2-3,6H2,1H3,(H,20,21,22);(H,6,7)

Standard InChI Key:  DXEOJQFQODTOGA-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 31 33  0  0  0  0  0  0  0  0999 V2000
    9.8675  -14.4414    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.2805  -15.1517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6892  -14.4389    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.5742  -15.5647    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.9905  -15.5647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6987  -15.1558    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.9905  -16.3824    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2816  -15.1920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2816  -16.0201    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9969  -16.4320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9969  -14.7760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7120  -15.1920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7165  -16.0166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5022  -16.2699    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.4950  -14.9344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9760  -15.5980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7873  -15.5117    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1239  -14.7629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6388  -14.0991    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8212  -14.1844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9450  -14.6776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4291  -15.3456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2519  -15.2597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5917  -14.5021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0984  -13.8339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2772  -13.9232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3348  -13.5152    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4292  -13.0794    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    7.7351  -15.9270    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    8.4108  -14.4140    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.8967  -15.0794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  2  1  0
  2  5  1  0
  5  6  1  0
  5  7  2  0
  8  9  1  0
  8 11  1  0
  9 10  1  0
 10 13  1  0
 12 11  1  0
 12 13  2  0
 13 14  1  0
 14 16  1  0
 15 12  1  0
 15 16  2  0
 15 20  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 18 21  1  0
 20 27  2  0
 25 28  1  0
 23 29  1  0
 24 30  1  0
 30 31  1  0
M  END

Associated Targets(Human)

KB-V1 (202 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
518A2 (464 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EA.hy 926 (491 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 471.17Molecular Weight (Monoisotopic): 468.9095AlogP: 3.83#Rotatable Bonds: 2
Polar Surface Area: 67.01Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 7.87CX Basic pKa: 8.49CX LogP: 3.05CX LogD: 2.73
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.60Np Likeness Score: -1.07

References

1. Gold M,Köhler L,Lanzloth C,Andronache I,Anant S,Dandawate P,Biersack B,Schobert R.  (2020)  Synthesis and bioevaluation of new vascular-targeting and anti-angiogenic thieno[2,3-d]pyrimidin-4(3H)-ones.,  189  [PMID:31958738] [10.1016/j.ejmech.2020.112060]

Source